209 related articles for article (PubMed ID: 35461764)
21. Hepatic Niemann-Pick C1-Like 1 exacerbates non-alcoholic fatty liver disease by re-absorbing specific biliary oxysterols.
Yamanashi Y; Takada T; Tanaka Y; Ogata Y; Toyoda Y; Ito SM; Kitani M; Oshida N; Okada K; Shoda J; Suzuki H
Biomed Pharmacother; 2022 Dec; 156():113877. PubMed ID: 36270257
[TBL] [Abstract][Full Text] [Related]
22. 4β-hydroxycholesterol as an endogenous CYP3A marker in cancer patients treated with taxanes.
de Graan AJ; Sparreboom A; de Bruijn P; de Jonge E; van der Holt B; Wiemer EA; Verweij J; Mathijssen RH; van Schaik RH
Br J Clin Pharmacol; 2015 Sep; 80(3):560-8. PubMed ID: 26119961
[TBL] [Abstract][Full Text] [Related]
23. Interactions of Oxysterols with Atherosclerosis Biomarkers in Subjects with Moderate Hypercholesterolemia and Effects of a Nutraceutical Combination (
Cicolari S; Pavanello C; Olmastroni E; Puppo MD; Bertolotti M; Mombelli G; Catapano AL; Calabresi L; Magni P
Nutrients; 2021 Jan; 13(2):. PubMed ID: 33525601
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of cellular cholesterol efflux by 25-hydroxycholesterol.
Kilsdonk EP; Morel DW; Johnson WJ; Rothblat GH
J Lipid Res; 1995 Mar; 36(3):505-16. PubMed ID: 7775862
[TBL] [Abstract][Full Text] [Related]
25. Oxysterols and Oxysterol Sulfates in Alzheimer's Disease Brain and Cerebrospinal Fluid.
Dias IHK; Shokr H; Shephard F; Chakrabarti L
J Alzheimers Dis; 2022; 87(4):1527-1536. PubMed ID: 35491790
[TBL] [Abstract][Full Text] [Related]
26. Selected plasma oxysterols as a potential multi-marker biosignature panel for Behçet's Disease.
Messedi M; Guidara W; Grayaa S; Khrouf W; Snoussi M; Bahloul Z; Bonnefont-Rousselot D; Lamari F; Ayadi F
J Steroid Biochem Mol Biol; 2022 Jul; 221():106122. PubMed ID: 35588947
[TBL] [Abstract][Full Text] [Related]
27. Plasma oxysterol profiling in children reveals 24-hydroxycholesterol as a potential marker for Autism Spectrum Disorders.
Grayaa S; Zerbinati C; Messedi M; HadjKacem I; Chtourou M; Ben Touhemi D; Naifar M; Ayadi H; Ayedi F; Iuliano L
Biochimie; 2018 Oct; 153():80-85. PubMed ID: 29730299
[TBL] [Abstract][Full Text] [Related]
28. Relationship between oxysterols and mild cognitive impairment in the elderly: a case-control study.
Liu Q; An Y; Yu H; Lu Y; Feng L; Wang C; Xiao R
Lipids Health Dis; 2016 Oct; 15(1):177. PubMed ID: 27724967
[TBL] [Abstract][Full Text] [Related]
29. Different functions of vitamin E homologues in the various types of cell death induced by oxysterols.
Suzuki A; Urano Y; Ishida T; Noguchi N
Free Radic Biol Med; 2021 Nov; 176():356-365. PubMed ID: 34648906
[TBL] [Abstract][Full Text] [Related]
30. Comparative performance of oral midazolam clearance and plasma 4β-hydroxycholesterol to explain interindividual variability in tacrolimus clearance.
Vanhove T; de Jonge H; de Loor H; Annaert P; Diczfalusy U; Kuypers DR
Br J Clin Pharmacol; 2016 Dec; 82(6):1539-1549. PubMed ID: 27501475
[TBL] [Abstract][Full Text] [Related]
31. On the rate of translocation in vitro and kinetics in vivo of the major oxysterols in human circulation: critical importance of the position of the oxygen function.
Meaney S; Bodin K; Diczfalusy U; Björkhem I
J Lipid Res; 2002 Dec; 43(12):2130-5. PubMed ID: 12454275
[TBL] [Abstract][Full Text] [Related]
32. Relationships between endogenous CYP3A markers and plasma amlodipine exposure and metabolism in early postpartum and non-peripartum women with hypertension.
Taguchi R; Naito T; Kubono N; Ogawa N; Itoh H; Kawakami J
Pregnancy Hypertens; 2019 Jul; 17():209-215. PubMed ID: 31487643
[TBL] [Abstract][Full Text] [Related]
33. 27-hydroxycholesterol decreases cell proliferation in colon cancer cell lines.
Warns J; Marwarha G; Freking N; Ghribi O
Biochimie; 2018 Oct; 153():171-180. PubMed ID: 30009860
[TBL] [Abstract][Full Text] [Related]
34. Effect of obesity and metabolic syndrome on plasma oxysterols and fatty acids in human.
Tremblay-Franco M; Zerbinati C; Pacelli A; Palmaccio G; Lubrano C; Ducheix S; Guillou H; Iuliano L
Steroids; 2015 Jul; 99(Pt B):287-92. PubMed ID: 25896943
[TBL] [Abstract][Full Text] [Related]
35. CYP3A Activity in End-of-Life Cancer Patients Measured by 4β-Hydroxycholesterol/cholesterol Ratio, in Men and Women.
Bergström H; Helde Frankling M; Klasson C; Lövgren Sandblom A; Diczfalusy U; Björkhem-Bergman L
Cancers (Basel); 2021 Sep; 13(18):. PubMed ID: 34572915
[TBL] [Abstract][Full Text] [Related]
36. 4beta-hydroxycholesterol as an endogenous marker for CYP3A4/5 activity. Stability and half-life of elimination after induction with rifampicin.
Diczfalusy U; Kanebratt KP; Bredberg E; Andersson TB; Böttiger Y; Bertilsson L
Br J Clin Pharmacol; 2009 Jan; 67(1):38-43. PubMed ID: 19006545
[TBL] [Abstract][Full Text] [Related]
37. [Screening of serum oxysterol biomarkers for colon cancer by liquid chromatography-tandem mass spectrometry].
Ma Z; Li Z; Wang H; Wang R; Han X
Se Pu; 2022 Jun; 40(6):541-546. PubMed ID: 35616199
[TBL] [Abstract][Full Text] [Related]
38. Antiepileptic drugs increase plasma levels of 4beta-hydroxycholesterol in humans: evidence for involvement of cytochrome p450 3A4.
Bodin K; Bretillon L; Aden Y; Bertilsson L; Broomé U; Einarsson C; Diczfalusy U
J Biol Chem; 2001 Oct; 276(42):38685-9. PubMed ID: 11514559
[TBL] [Abstract][Full Text] [Related]
39. Quantification of oxysterols in human plasma and red blood cells by liquid chromatography high-resolution tandem mass spectrometry.
Pataj Z; Liebisch G; Schmitz G; Matysik S
J Chromatogr A; 2016 Mar; 1439():82-88. PubMed ID: 26607314
[TBL] [Abstract][Full Text] [Related]
40. Differential effects of 24-hydroxycholesterol and 27-hydroxycholesterol on tyrosine hydroxylase and alpha-synuclein in human neuroblastoma SH-SY5Y cells.
Rantham Prabhakara JP; Feist G; Thomasson S; Thompson A; Schommer E; Ghribi O
J Neurochem; 2008 Dec; 107(6):1722-9. PubMed ID: 19014385
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
